by Seini Moimoi | May 30, 2025
CytomX Therapeutics (NASDAQ: CTMX) is a clinical-stage biotechnology company developing novel conditionally activated, masked biologics designed to be localized to the tumor microenvironment. 
by Seini Moimoi | May 12, 2025
Rivus Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to treating cardiometabolic diseases driven by obesity. 
by Seini Moimoi | Mar 12, 2025
Mobia Medical is a medical technology company commercializing the Vivistim System, a novel vagus nerve stimulation (VNS) therapy to improve upper extremity motor function in stroke patients. 
by Seini Moimoi | Jan 16, 2025
Aviceda Therapeutics is a biotechnology company developing next-generation immunomodulators with a proprietary High Affinity Ligands of Siglecs (HALOS™) nanotechnology platform to alleviate chronic, non-resolving inflammation. 
by Seini Moimoi | Jan 16, 2025
FIRE1 is a medical technology company developing the Norm™ heart failure management system that enables patients to engage in physician directed self-management of heart failure.